Stay updated on Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial
Sign up to get notified when there's something new on the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page.
Latest updates to the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.3%
- Check15 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe website has added new features for data download options, while several key government health-related links have been removed.SummaryDifference14%
- Check36 days agoChange DetectedSeveral new government health and information websites have been added, including HHS, NIH, NLM, NCBI, and USA.gov.SummaryDifference0.7%
- Check43 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new download options in various file formats and an extensive selection of data fields for studies.SummaryDifference16%
- Check51 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.3%
Stay in the know with updates to Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide in Heart Failure, Obesity and Diabetes Clinical Trial page.